Your browser doesn't support javascript.
Longitudinal sampling sheds light on SARS-CoV-2 fecal shedding dynamics.
Coryell, Michael P; Carlson, Paul E.
  • Coryell MP; Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Carlson PE; Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: paul.carlson@fda.hhs.gov.
Med (N Y) ; 3(6): 351-352, 2022 06 10.
Article in English | MEDLINE | ID: covidwho-1946048
ABSTRACT
Persistent fecal shedding of SARS-CoV-2 viral RNA has remained a clinical feature of interest throughout the COVID-19 pandemic. In this issue of Med, Natarajan et al. report fecal shedding dynamics of individuals diagnosed with mild-to-moderate COVID-19 disease and sampled longitudinally for up to 10 months1.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Med (N Y) Year: 2022 Document Type: Article Affiliation country: J.medj.2022.05.015

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Med (N Y) Year: 2022 Document Type: Article Affiliation country: J.medj.2022.05.015